{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T20:17:33Z","timestamp":1788898653615,"version":"build-2803163510"},"reference-count":166,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.bioorg.2024.107819","type":"journal-article","created":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T11:13:26Z","timestamp":1726226006000},"page":"107819","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Recent advances in the natural product analogues for the treatment of neurodegenerative diseases"],"prefix":"10.1016","volume":"153","author":[{"given":"Jinling","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengmeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhichao","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiatong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiqiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingyou","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2024.107819_b0005","doi-asserted-by":"crossref","first-page":"12854","DOI":"10.3390\/ijms232112854","article-title":"Neurodegenerative Diseases: From Molecular Basis to Therapy","volume":"23","author":"Agnello","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2024.107819_b0010","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1093\/labmed\/lmaa062","article-title":"Neurogranin as a Novel Biomarker in Alzheimer's Disease","volume":"52","author":"Agnello","year":"2019","journal-title":"Lab. Med."},{"key":"10.1016\/j.bioorg.2024.107819_b0015","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.ijbiomac.2019.02.148","article-title":"Molecular chaperones biochemistry and role in neurodegenerative diseases","volume":"131","author":"Chaari","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bioorg.2024.107819_b0020","first-page":"49","article-title":"The Neuroprotective Effect of Ginsenoside Compound K on Neurodegenerative Diseases","volume":"11","author":"Jiang","year":"2021","journal-title":"Acta. Neuropharmacol."},{"key":"10.1016\/j.bioorg.2024.107819_b0025","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s11357-022-00707-z","article-title":"The potential of hyperbaric oxygen as a therapy for neurodegenerative diseases","volume":"45","author":"Mensah-Kane","year":"2023","journal-title":"Geroscience"},{"key":"10.1016\/j.bioorg.2024.107819_b0030","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1146\/annurev-biochem-061516-045049","article-title":"Propagation of Protein Aggregation in Neurodegenerative Diseases","volume":"88","author":"Vaquer-Alicea","year":"2019","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.bioorg.2024.107819_b0035","doi-asserted-by":"crossref","first-page":"9290","DOI":"10.3390\/ijms22179290","article-title":"Acetylcholinesterase Inhibitors in the Treatment of Neurodegenerative Diseases and the Role of Acetylcholinesterase in their Pathogenesis","volume":"22","author":"Walczak-Nowick","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2024.107819_b0040","doi-asserted-by":"crossref","first-page":"11847","DOI":"10.3390\/ijms222111847","article-title":"Insights into the Pathogenesis of Neurodegenerative Diseases: Focus on Mitochondrial Dysfunction and Oxidative Stress","volume":"22","author":"Jurcau","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2024.107819_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115726","article-title":"Natural products as potential lead compounds to develop new antiviral drugs over the past decade","volume":"260","author":"Zhao","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107819_b0050","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.jalz.2016.01.012","article-title":"Molecular genetics of early-onset Alzheimer's disease revisited","volume":"12","author":"Cacace","year":"2016","journal-title":"Alzheimer's & Dement"},{"key":"10.1016\/j.bioorg.2024.107819_b0055","first-page":"1009","article-title":"Parkin, PINK1, DJ-1 and mitochondria dysfunction with Parkinson\u2019s disease, Chinese Bulletin of","volume":"22","author":"Yang","year":"2010","journal-title":"Life Sciences"},{"key":"10.1016\/j.bioorg.2024.107819_b0060","first-page":"650","article-title":"FAN1 modifies Huntington's disease progression by stabilizing the expanded HTT CAG repeat","volume":"28","author":"Goold","year":"2019","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.bioorg.2024.107819_b0065","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1038\/nn2014","article-title":"Local self-renewal can sustain CNS microglia maintenance and function throughout adult life","volume":"10","author":"Ajami","year":"2007","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bioorg.2024.107819_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2020.113310","article-title":"Microglia and macrophage metabolism in CNS injury and disease: The role of immunometabolism in neurodegeneration and neurotrauma","volume":"329","author":"Devanney","year":"2020","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bioorg.2024.107819_b0075","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.4103\/1673-5374.387965","article-title":"Rethinking neurodegenerative diseases: neurometabolic concept linking lipid oxidation to diseases in the central nervous system","volume":"19","author":"Helgud\u00f3ttir","year":"2024","journal-title":"Neural. Regen. Res."},{"key":"10.1016\/j.bioorg.2024.107819_b0080","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ijpharm.2014.04.015","article-title":"Development, characterization and application of in situ gel systems for intranasal delivery of tacrine","volume":"468","author":"Qian","year":"2014","journal-title":"Int. J. Pharmaceut."},{"key":"10.1016\/j.bioorg.2024.107819_b0085","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.2174\/1389557521666210212151127","article-title":"Multi-Target Drug Design of Anti-Alzheimer\u2019s Disease based on Tacrine","volume":"21","author":"Tian","year":"2021","journal-title":"Mini-Rev. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107819_b0090","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1517\/17425251003592137","article-title":"Galantamine for Alzheimer\u2019s disease","volume":"6","author":"Prvulovic","year":"2010","journal-title":"Expert. Opin. Drug Metab. Toxicol"},{"key":"10.1016\/j.bioorg.2024.107819_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2020.113409","article-title":"Galantamine-Memantine combination in the treatment of Alzheimer's disease and beyond","volume":"293","author":"Koola","year":"2020","journal-title":"Psychiat. Res."},{"key":"10.1016\/j.bioorg.2024.107819_b0100","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1001\/archneurol.2012.85","article-title":"Antioxidants for Alzheimer Disease: A Randomized Clinical Trial With Cerebrospinal Fluid Biomarker Measures","volume":"69","author":"Galasko","year":"2012","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.bioorg.2024.107819_b0105","first-page":"898","article-title":"Research advances of drug combination treatment in Alzheimer disease","volume":"21","author":"Zhu","year":"2021","journal-title":"J. Neurosci. Ment. Health"},{"key":"10.1016\/j.bioorg.2024.107819_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116169","article-title":"Design, synthesis and biological evaluation of carbamate derivatives incorporating multifunctional carrier scaffolds as pseudo-irreversible cholinesterase inhibitors for the treatment of Alzheimer's disease","volume":"267","author":"Liu","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107819_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.107026","article-title":"Design, synthesis, and biological evaluation of novel capsaicin-tacrine hybrids as multi-target agents for the treatment of Alzheimer's disease","volume":"143","author":"Long","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2024.107819_b0120","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3390\/molecules23010040","article-title":"Dopamine and Levodopa Prodrugs for the Treatment of Parkinson\u2019s Disease","volume":"23","author":"Haddad","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2024.107819_b0125","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1136\/acupmed-2016-011342","article-title":"Efficacy and safety of acupuncture combined with Madopar for Parkinson\u2019s disease: a systematic review with meta-analysis","volume":"35","author":"Liu","year":"2017","journal-title":"Acupunct. Med."},{"key":"10.1016\/j.bioorg.2024.107819_b0130","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1080\/14737175.2019.1592677","article-title":"Extended-Release Amantadine for Levodopa-Induced Dyskinesia","volume":"19","author":"Dashtipour","year":"2019","journal-title":"Expert. Rev. Neurother."},{"key":"10.1016\/j.bioorg.2024.107819_b0135","first-page":"202","article-title":"The US FDA approved Ocrevus (ocrelizumab) for the treatment of multiple sclerosis","volume":"33","author":"Xia","year":"2017","journal-title":"Journal of Guangdong Pharmaceutical"},{"key":"10.1016\/j.bioorg.2024.107819_b0140","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1080\/14737175.2023.2289572","article-title":"An update on combination therapies for multiple sclerosis: where are we now?","volume":"23","author":"Sorensen","year":"2023","journal-title":"Expert. Rev. Neurother."},{"key":"10.1016\/j.bioorg.2024.107819_b0145","first-page":"1","article-title":"Safety of long-term intrathecal methotrexate in progressive forms of MS","volume":"12","author":"Stark","year":"2019","journal-title":"Ther. Adv. Neurol. Diso."},{"key":"10.1016\/j.bioorg.2024.107819_b0150","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/s41586-023-06926-4","article-title":"Transport and inhibition mechanisms of human VMAT2","volume":"626","author":"Wu","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2024.107819_b0155","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.2147\/TCRM.S279332","article-title":"Clinical Utility of Deutetrabenazine as a Treatment Option for Chorea Associated with Huntington's Disease and Tardive Dyskinesia","volume":"19","author":"Frank","year":"2023","journal-title":"Ther. Clin. Risk Manag."},{"key":"10.1016\/j.bioorg.2024.107819_b0160","first-page":"702","article-title":"Safety of tetrabenazine and deutetrabenazine deuterium based on FAERS database","volume":"38","author":"Yin","year":"2023","journal-title":"Drugs & Clinic"},{"key":"10.1016\/j.bioorg.2024.107819_b0165","doi-asserted-by":"crossref","first-page":"e5736","DOI":"10.1002\/pds.5736","article-title":"Adherence to riluzole therapy in patients with amyotrophic lateral sclerosis in three Italian regions-The CAESAR study","volume":"33","author":"Giometto","year":"2024","journal-title":"Pharmacoepidem. Dr. s."},{"key":"10.1016\/j.bioorg.2024.107819_b0170","first-page":"1430","article-title":"Clinical efficacy and safety of riluzole combined with Edaravone injection in the treatment of amyotrophic lateral sclerosis","volume":"50","author":"Chen","year":"2021","journal-title":"Shaanxi Medical Journal"},{"key":"10.1016\/j.bioorg.2024.107819_b0175","doi-asserted-by":"crossref","first-page":"e12715","DOI":"10.1111\/acel.12715","article-title":"The mitochondrial ATP synthase is a shared drug target for aging and dementia","volume":"17","author":"Goldberg","year":"2018","journal-title":"Aging Cell"},{"key":"10.1016\/j.bioorg.2024.107819_b0180","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s40263-017-0434-z","article-title":"Elucidating the A\u03b242 Anti-Aggregation Mechanism of Action of Tramiprosate in Alzheimer\u2019s Disease: Integrating Molecular Analytical Methods, Pharmacokinetic and Clinical Data","volume":"31","author":"Kocis","year":"2017","journal-title":"CNS Drugs"},{"key":"10.1016\/j.bioorg.2024.107819_b0185","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/s41422-019-0216-x","article-title":"Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit Alzheimer\u2019s disease progression","volume":"29","author":"Wang","year":"2019","journal-title":"Cell Res."},{"key":"10.1016\/j.bioorg.2024.107819_b0190","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3389\/fnagi.2020.00155","article-title":"Prevention of Early Alzheimer\u2019s Disease by Erinacine A-Enriched Hericium erinaceus Mycelia Pilot Double-Blind Placebo-Controlled Study","volume":"12","author":"Li","year":"2020","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.bioorg.2024.107819_b0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116399","article-title":"Morphing cholinesterase inhibitor amiridine into multipotent drugs for the treatment of Alzheimer's disease","volume":"173","author":"Mezeiova","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bioorg.2024.107819_b0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107152","article-title":"A comprehensive review of multi-target directed ligands in the treatment of Alzheimer's disease","volume":"144","author":"Pathak","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2024.107819_b0205","first-page":"1006","article-title":"Novel Tacrine-Scutellarin Hybrids as Multipotent Anti-Alzheimer\u2019s Agents: Design","volume":"22","author":"Spilovska","year":"2017","journal-title":"Synthesis and Biological Evaluation, Molecules"},{"key":"10.1016\/j.bioorg.2024.107819_b0210","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/j.bmcl.2015.02.015","article-title":"Design, synthesis and evaluation of novel 5,6,7-trimethoxyflavone-6-chlorotacrine hybrids as potential multifunctional agents for the treatment of Alzheimer\u2019s disease, Bioorg","volume":"25","author":"Liao","year":"2015","journal-title":"Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2024.107819_b0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2021.105976","article-title":"Novel chrysin derivatives as hidden multifunctional agents for anti-Alzheimer's disease: design, synthesis and in vitro evaluation","volume":"166","author":"Liu","year":"2021","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.bioorg.2024.107819_b0220","doi-asserted-by":"crossref","first-page":"6154","DOI":"10.1080\/07391102.2020.1803136","article-title":"Exploring 3-Benzyloxyflavones as new lead cholinesterase inhibitors: synthesis, structure-activity relationship and molecular modelling simulations","volume":"39","author":"Mughal","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.bioorg.2024.107819_b0225","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ejmech.2017.04.054","article-title":"Design, synthesis and evaluation of scutellarein-O-acetamidoalkylbenzylamines as potential multifunctional agents for the treatment of Alzheimer\u2019s disease","volume":"135","author":"Sang","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107819_b0230","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ejmech.2016.06.022","article-title":"Design, synthesis and evaluation of 4-dimethylamine flavonoid derivatives as potential multifunctional anti-Alzheimer agents","volume":"122","author":"Luo","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107819_b0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.102960","article-title":"Synthesis and biological evaluation of flavone-8-acrylamide derivatives as potential multi-target-directed anti Alzheimer agents and investigation of binding mechanism with acetylcholinesterase","volume":"88","author":"Shaik","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2024.107819_b0240","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1016\/j.bmcl.2013.02.095","article-title":"Design, synthesis and evaluation of flavonoid derivatives as potential multifunctional acetylcholinesterase inhibitors against Alzheimer\u2019s disease","volume":"23","author":"Li","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2024.107819_b0245","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.bmc.2015.12.031","article-title":"Design, synthesis and evaluation of novel 7-aminoalkyl-substituted flavonoid derivatives with improved cholinesterase inhibitory activities","volume":"24","author":"Luo","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107819_b0250","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.ejmech.2015.02.063","article-title":"Design, synthesis and evaluation of scutellarein-O-alkylamines as multifunctional agents for the treatment of Alzheimer's disease","volume":"94","author":"Sang","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107819_b0255","doi-asserted-by":"crossref","first-page":"7275","DOI":"10.1016\/j.bmc.2013.09.061","article-title":"Design, synthesis and evaluation of novel 4-dimethylamine flavonoid derivatives as potential multi-functional anti-Alzheimer agents","volume":"21","author":"Luo","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107819_b0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.105760","article-title":"Design, synthesis and evaluation of novel scutellarin and scutellarein-N, N-bis-substituted carbamate-L-amino acid derivatives as potential multifunctional therapeutics for Alzheimer\u2019s disease","volume":"122","author":"Wu","year":"2022","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2024.107819_b0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114216","article-title":"A multifunctional anti-AD approach: Design, synthesis, X-ray crystal structure, biological evaluation and molecular docking of chrysin derivatives","volume":"233","author":"Yang","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107819_b0270","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.bmc.2016.11.048","article-title":"Multitarget drug design strategy against Alzheimer\u2019s disease: Homoisoflavonoid Mannich base derivatives serve as acetylcholinesterase and monoamine oxidase B dual inhibitors with multifunctional properties","volume":"25","author":"Li","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107819_b0275","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.ejmech.2014.02.045","article-title":"Design, synthesis and evaluation of genistein-O-alkylbenzylamines as potential multifunctional agents for the treatment of Alzheimer's disease","volume":"76","author":"Qiang","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107819_b0280","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ejmech.2019.02.053","article-title":"Design, synthesis, and evaluation of isoflavone analogs as multifunctional agents for the treatment of Alzheimer's disease","volume":"168","author":"Wang","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107819_b0285","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1080\/14756366.2017.1347163","article-title":"Discovery of novel isoflavone derivatives as AChE\/BuChE dual-targeted inhibitors: synthesis, biological evaluation and molecular modelling","volume":"32","author":"Feng","year":"2017","journal-title":"J. Enzym. Inhib. Med. Ch."},{"key":"10.1016\/j.bioorg.2024.107819_b0290","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.3390\/molecules22071067","article-title":"Design, Synthesis and Evaluation of Hesperetin Derivatives as Potential Multifunctional Anti-Alzheimer Agents","volume":"22","author":"Li","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2024.107819_b0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2021.128306","article-title":"Design, synthesis, and cholinesterase inhibition assay of liquiritigenin derivatives as anti-Alzheimer's activity","volume":"52","author":"Guan","year":"2021","journal-title":"Bioorg. & Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2024.107819_b0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2020.109350","article-title":"Biological evaluation of 7-O-amide hesperetin derivatives as multitarget-directed ligands for the treatment of Alzheimer's disease","volume":"334","author":"Wu","year":"2021","journal-title":"Chem-Biol. Interact."},{"key":"10.1016\/j.bioorg.2024.107819_b0305","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1080\/14756366.2022.2041627","article-title":"Development of naringenin-O-alkylamine derivatives as multifunctional agents for the treatment of Alzheimer\u2019s disease","volume":"37","author":"Yang","year":"2022","journal-title":"J. Enzym. Inhib. Med. Ch."},{"key":"10.1016\/j.bioorg.2024.107819_b0310","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2174\/1573409918666220804153754","article-title":"Design Synthesis and in vitro Evaluation of Tacrine-flavone Hybrids as Multifunctional Cholinesterase Inhibitors for Alzheimer\u2019s Disease","volume":"18","author":"Remya","year":"2022","journal-title":"Curr. Comput-Aid. Drug"},{"key":"10.1016\/j.bioorg.2024.107819_b0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiolchem.2022.107748","article-title":"Exploring enzyme inhibition profiles of novel halogenated chalcone derivatives on some metabolic enzymes: Synthesis, characterization and molecular modeling studies","volume":"100","author":"Anil","year":"2022","journal-title":"Comput. Biol. Chem."},{"key":"10.1016\/j.bioorg.2024.107819_b0320","doi-asserted-by":"crossref","first-page":"e2100372","DOI":"10.1002\/ardp.202100372","article-title":"Design and synthesis of novel chalcone derivatives and evaluation of their inhibitory activities against acetylcholinesterase","volume":"355","author":"Ceyhun","year":"2021","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.bioorg.2024.107819_b0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105572","article-title":"Novel thiophene Chalcones-Coumarin as acetylcholinesterase inhibitors: Design, synthesis, biological evaluation, molecular docking, ADMET prediction and molecular dynamics simulation","volume":"119","author":"Hasan","year":"2022","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2024.107819_b0330","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.bioorg.2019.03.043","article-title":"Design, synthesis and evaluation of chalcone Mannich base derivatives as multifunctional agents for the potential treatment of Alzheimer\u2019s disease","volume":"87","author":"Zhang","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2024.107819_b0335","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/cbdd.12514","article-title":"Novel Potent and Selective Acetylcholinesterase Inhibitors as Potential Drugs for the Treatment of Alzheimer's Disease: Synthesis, Pharmacological Evaluation, and Molecular Modeling of Amino-Alkyl-Substituted Fluoro-Chalcones Derivatives","volume":"86","author":"Liu","year":"2015","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.bioorg.2024.107819_b0340","doi-asserted-by":"crossref","first-page":"580","DOI":"10.3109\/14756366.2015.1050009","article-title":"Design, synthesis and preliminary structure\u2013activity relationship investigation of nitrogen-containing chalcone derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors: a further study based on Flavokawain B Mannich base derivatives","volume":"31","author":"Liu","year":"2015","journal-title":"J. Enzym. Inhib. Med. Ch."},{"key":"10.1016\/j.bioorg.2024.107819_b0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111737","article-title":"Development of chalcone-O-alkylamine derivatives as multifunctional agents against Alzheimer's disease","volume":"183","author":"Bai","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107819_b0350","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ejmech.2019.07.021","article-title":"Design, synthesis, in-silico and biological evaluation of novel chalcone derivatives as multi-function agents for the treatment of Alzheimer's disease","volume":"180","author":"Sang","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107819_b0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103477","article-title":"Flurbiprofen-chalcone hybrid Mannich base derivatives as balanced multifunctional agents against Alzheimer\u2019s disease: Design, synthesis and biological evaluation","volume":"94","author":"Tian","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2024.107819_b0360","article-title":"Ultrasound-assisted synthesis of novel chalcone, heterochalcone and bis-chalcone derivatives and the evaluation of their antioxidant properties and as acetylcholinesterase inhibitors","volume":"90","author":"Efra\u00edn","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2024.107819_b0365","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.ejmech.2016.12.009","article-title":"Aurone Mannich base derivatives as promising multifunctional agents with acetylcholinesterase inhibition, anti-\u03b2-amyloid aggragation and neuroprotective properties for the treatment of Alzheimer's disease","volume":"126","author":"Li","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107819_b0370","doi-asserted-by":"crossref","unstructured":"M. Mostofi, G. Mohammadi Ziarani, M. Mahdavi, A. Moradi, H. Nadri, S. Emami, H. Alinezhad, A. Foroumadi, A. Shafiee, Synthesis and structure-activity relationship study of benzofuran-based chalconoids bearing benzylpyridinium moiety as potent acetylcholinesterase inhibitors, Eur. J. Med. Chem. 103 (2015) 361-369.","DOI":"10.1016\/j.ejmech.2015.08.061"},{"key":"10.1016\/j.bioorg.2024.107819_b0375","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2019.126927","article-title":"Design, synthesis and anti-Alzheimer's disease activity study of xanthone derivatives based on multi-target strategy","volume":"30","author":"Kou","year":"2020","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2024.107819_b0380","doi-asserted-by":"crossref","unstructured":"C.A. Men\u00e9ndez, B. Biscussi, S. Accordino, A. Paula Murray, D.C. Gerbino, G.A. Appignanesi, Design, synthesis and biological evaluation of 1,3-dihydroxyxanthone derivatives: Effective agents against acetylcholinesterase, Bioorg. Chem. 75 (2017) 201-209.","DOI":"10.1016\/j.bioorg.2017.09.012"},{"key":"10.1016\/j.bioorg.2024.107819_b0385","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1080\/14756366.2021.1882452","article-title":"New 3-O-substituted xanthone derivatives as promising acetylcholinesterase inhibitors","volume":"36","author":"Loh","year":"2021","journal-title":"J. Enzym. Inhib. Med. Ch."},{"key":"10.1016\/j.bioorg.2024.107819_b0390","first-page":"1","article-title":"Design, Synthesis and Biological Evaluation of Xanthone Derivatives for Possible Treatment of Alzheimer's Disease Based on Multi-Target Strategy","volume":"17","author":"Yang","year":"2020","journal-title":"Chemi. Biodivers."},{"key":"10.1016\/j.bioorg.2024.107819_b0395","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/1752-153X-7-78","article-title":"Synthesis and biological evaluation of 1, 3-dihydroxyxanthone mannich base derivatives as anticholinesterase agents","volume":"7","author":"Qin","year":"2013","journal-title":"Chem. Cent. J."},{"key":"10.1016\/j.bioorg.2024.107819_b0400","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2021.116074","article-title":"Novel 3-benzylidene\/benzylphthalide Mannich base derivatives as potential multifunctional agents for the treatment of Alzheimer\u2019s disease","volume":"35","author":"Cao","year":"2021","journal-title":"Bioorgan. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107819_b0405","doi-asserted-by":"crossref","unstructured":"E. Riazimontazer, H. Sadeghpour, H. Nadri, A. Sakhteman, T. T\u00fcyl\u00fc K\u00fc\u00e7\u00fckk\u0131l\u0131n\u00e7, R. Miri, N. Edraki, Design, synthesis and biological activity of novel tacrine-isatin Schiff base hybrid derivatives, Bioorg. Chem. 89 (2019) 103006.","DOI":"10.1016\/j.bioorg.2019.103006"},{"key":"10.1016\/j.bioorg.2024.107819_b0410","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ejmech.2013.02.014","article-title":"Synthesis and evaluation of 7,8-dehydrorutaecarpine derivatives as potential multifunctional agents for the treatment of Alzheimer's disease","volume":"63","author":"He","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107819_b0415","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1002\/cmdc.201000322","article-title":"Novel Huprine Derivatives with Inhibitory Activity toward \u03b2-Amyloid Aggregation and Formation as Disease-Modifying Anti-Alzheimer Drug Candidates","volume":"5","author":"G\u00f3mez","year":"2010","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bioorg.2024.107819_b0420","doi-asserted-by":"crossref","unstructured":"P. Camps, R.E. Achab, D.M. Go\u00a8rbig, J. Morral, Synthesis, in Vitro Pharmacology, and Molecular Modeling of Very Potent Tacrine-Huperzine A Hybrids as Acetylcholinesterase Inhibitors of Potential Interest for the Treatment of Alzheimer\u2019s Disease, J. Med. Chem. 42 (1999) 3227-3242.","DOI":"10.1021\/jm980620z"},{"key":"10.1016\/j.bioorg.2024.107819_b0425","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1038\/aps.2009.91","article-title":"Novel 16-substituted bifunctional derivatives of huperzine B: multifunctional cholinesterase inhibitors","volume":"30","author":"Shi","year":"2009","journal-title":"Acta. Pharmacol. Sin."},{"key":"10.1016\/j.bioorg.2024.107819_b0430","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1016\/j.ejmech.2011.02.005","article-title":"Syntheses and characterization of novel oxoisoaporphine derivatives as dual inhibitors for cholinesterases and amyloid beta aggregation","volume":"46","author":"Li","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107819_b0435","first-page":"4901","article-title":"Synthesis of phenserine analogues and evaluation of their cholinesterase inhibitory activities, Bioorgan","volume":"20","author":"Shinada","year":"2012","journal-title":"Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107819_b0440","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113554","article-title":"Design, synthesis and biological evaluation of harmine derivatives as potent GSK-3\u03b2\/DYRK1A dual inhibitors for the treatment of Alzheimer's disease","volume":"222","author":"Liu","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107819_b0445","first-page":"841","article-title":"Synthesis, anticholinesterase activity and molecular modeling studies of novel carvacrol-substituted amide derivatives","volume":"38","author":"Belma","year":"2019","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.bioorg.2024.107819_b0450","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/j.1747-0285.2012.01435.x","article-title":"Synthesis and Biological Evaluation of 3-thiazolocoumarinyl Schiff-base Derivatives as Cholinesterase Inhibitors","volume":"80","author":"Rabia","year":"2012","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.bioorg.2024.107819_b0455","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1021\/ml300207a","article-title":"Novel Inverse Binding Mode of Indirubin Derivatives Yields Improved Selectivity for DYRK Kinases","volume":"4","author":"Myrianthopoulos","year":"2012","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2024.107819_b0460","doi-asserted-by":"crossref","first-page":"19924","DOI":"10.1021\/acsomega.1c02875","article-title":"In Silico-Guided Rational Drug Design and Semi-synthesis of C(2)-Functionalized Huperzine A Derivatives as Acetylcholinesterase Inhibitors","volume":"6","author":"Anukanon","year":"2021","journal-title":"ACS Omega."},{"key":"10.1016\/j.bioorg.2024.107819_b0465","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1016\/j.bmcl.2015.05.034","article-title":"Meridianin derivatives as potent Dyrk1A inhibitors and neuroprotective agents","volume":"25","author":"Yadav","year":"2015","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2024.107819_b0470","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1002\/ddr.21998","article-title":"Design, synthesis, and structure-activity relationship of caffeine-based triazoles as dual AChE and BACE-1 inhibitors","volume":"83","author":"Sharma","year":"2022","journal-title":"Drug Develop. Res."},{"key":"10.1016\/j.bioorg.2024.107819_b0475","unstructured":"A. Ahmed, S. Akhtar, N. Mushtaq, S. Haider, R. Munawar, H. Ahmed Siddique, A. Akram, Z. S. Saify, M. Arif, 1,3-di-4-piperidylpropane derivatives as potential acetyl cholinesterase antagonists: Molecular docking, synthesis, and biological evaluation, Pak. J. Pharm. Sci. 34 (2021) 855-860."},{"key":"10.1016\/j.bioorg.2024.107819_b0480","doi-asserted-by":"crossref","unstructured":"N. Maafi, F. Pidan\u00fd, J. Ma\u0159\u00edkov\u00e1, J. Kor\u00e1be\u010dn\u00fd, D. Hulcov\u00e1, T. Ku\u010dera, M. Schmidt, L. A. Shammari, M. \u0160pul\u00e1k, M. Carmen Catapano, M. Mecava, L. Prchal, J. Kune\u0161, J. Janou\u0161ek, E. Kohelov\u00e1, J. Jen\u010do, L. Nov\u00e1kov\u00e1, L. Cahl\u00edkov\u00e1, Derivatives of montanine-type alkaloids and their implication for the treatment of Alzheimer's disease: Synthesis, biological activity and in silico study, Bioorg. Med. Chem. Lett. 51 (2021) 128374.","DOI":"10.1016\/j.bmcl.2021.128374"},{"key":"10.1016\/j.bioorg.2024.107819_b0485","doi-asserted-by":"crossref","first-page":"11231","DOI":"10.3390\/ijms231911231","article-title":"Novel Morpholine-Bearing Quinoline Derivatives as Potential Cholinesterase Inhibitors: The Influence of Amine, Carbon Linkers and Phenylamino Groups","volume":"23","author":"Liu","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2024.107819_b0490","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/minf.201900125","article-title":"Aporphinoid Alkaloids Derivatives as Selective Cholinesterases Inhibitors: Biological Evaluation and Docking Study","volume":"39","author":"Cavallaro","year":"2020","journal-title":"Mol. Inform."},{"key":"10.1016\/j.bioorg.2024.107819_b0495","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ejmech.2019.05.055","article-title":"Design, synthesis, and biological evaluation of rutacecarpine derivatives as multitarget-directed ligands for the treatment of Alzheimer's disease","volume":"177","author":"Wu","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107819_b0500","doi-asserted-by":"crossref","unstructured":"E. Kohelov\u00e1, R. Pe\u0159inov\u00e1, N. Maafi, J. Kor\u00e1be\u010dn\u00fd, D. Hulcov\u00e1, J. Ma\u0159\u00edkov\u00e1, T. Ku\u010dera, L. Mart\u00ednez Gonz\u00e1lez, M. Hrabinova, K. Vor\u010d\u00e1kov\u00e1, L. Nov\u00e1kov\u00e1, A.D. Simone, R. Havelek, L. Cahl\u00edkov\u00e1, Derivatives of the \u03b2-Crinane Amaryllidaceae Alkaloid Haemanthamine as Multi-Target Directed Ligands for Alzheimer\u2019s Disease, Molecules 24 (2019) 1307.","DOI":"10.3390\/molecules24071307"},{"key":"10.1016\/j.bioorg.2024.107819_b0505","first-page":"371","article-title":"Synthesis, pharmacological study and docking calculations of new benzo[f]coumarin derivatives as dual inhibitors of enzymatic systems involved in neurodegenerative diseases, Future","volume":"6","author":"Matos","year":"2014","journal-title":"Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107819_b0510","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ejmech.2015.10.046","article-title":"Synthesis, pharmacological assessment, molecular modeling and in silico studies of fused tricyclic coumarin derivatives as a new family of multifunctional anti-Alzheimer agents","volume":"107","author":"Shaik","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107819_b0515","first-page":"146","article-title":"Design, synthesis and biological evaluation of coumarin alkylamines as potent and selective dual binding site inhibitors of acetylcholinesterase, Bioorgan","volume":"21","author":"Catto","year":"2013","journal-title":"Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107819_b0520","doi-asserted-by":"crossref","unstructured":"S. Montanari, M. Bartolini, P. Neviani, F. Belluti, S. Gobbi, L. Pruccoli, A. Tarozzi, F. Falchi, V. Andrisano, P. Miszta, A. Cavalli A, S. Filipek, A. Bisi, A. Rampa, Multitarget Strategy to Address Alzheimer\u2019s Disease: Design, Synthesis, Biological Evaluation, and Computational Studies of Coumarin-Based Derivatives, ChemMedChem 11 (2016) 1296-1308.","DOI":"10.1002\/cmdc.201500392"},{"key":"10.1016\/j.bioorg.2024.107819_b0525","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2019.126900","article-title":"Synthesis and biological evaluation of 4-arylcoumarins as potential anti-Alzheimer\u2019s disease agents","volume":"30","author":"Yun","year":"2020","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2024.107819_b0530","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ejmech.2018.01.055","article-title":"Design, synthesis and biological evaluation of new coumarin-dithiocarbamate hybrids as multifunctional agents for the treatment of Alzheimer's disease","volume":"146","author":"Jiang","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107819_b0535","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.bioorg.2016.07.013","article-title":"Design, synthesis and biological evaluation of coumarin derivatives as novel acetylcholinesterase inhibitors that attenuate H2O2-induced apoptosis in SH-SY5Y cells","volume":"68","author":"Yao","year":"2016","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2024.107819_b0540","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.bioorg.2015.09.009","article-title":"Synthesis, cholinesterase inhibition and molecular modelling studies of coumarin linked thiourea derivatives","volume":"63","author":"Saeed","year":"2015","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2024.107819_b0545","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.bmcl.2007.09.100","article-title":"Multi-target-directed coumarin derivatives: hAChE and BACE1 inhibitors as potential anti-Alzheimer compounds","volume":"18","author":"Piazzi","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2024.107819_b0550","doi-asserted-by":"crossref","unstructured":"S.M. Bagheri, M. Khoobi, H. Nadri, A. Moradi, S. Emami, L. Jalili-Baleh, F. Jafarpour, F. Homayouni Moghadam, A. Foroumadi, A. Shafiee, Synthesis and Anticholinergic Activity of 4\u2010hydroxycoumarin Derivatives Containing Substituted Benzyl\u20101,2,3\u2010triazole Moiety, Chem. Biol. Drug Des. 86 (2015) 1215-1220.","DOI":"10.1111\/cbdd.12588"},{"key":"10.1016\/j.bioorg.2024.107819_b0555","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1080\/14756366.2016.1256883","article-title":"Design, synthesis and evaluation of novel cinnamic acid derivatives bearing N-benzyl pyridinium moiety as multifunctional cholinesterase inhibitors for Alzheimer\u2019s disease","volume":"32","author":"Lan","year":"2017","journal-title":"J. Enzym. Inhib. Med. Ch."},{"key":"10.1016\/j.bioorg.2024.107819_b0560","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1021\/acschemneuro.8b00530","article-title":"Design, Synthesis, and Evaluation of Novel Ferulic Acid Derivatives as Multi-Target-Directed Ligands for the Treatment of Alzheimer\u2019s Disease","volume":"10","author":"Sang","year":"2018","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.bioorg.2024.107819_b0565","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103413","article-title":"Design, synthesis and evaluation of novel ferulic acid derivatives as multi-target-directed ligands for the treatment of Alzheimer\u2019s disease","volume":"94","author":"Lan","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2024.107819_b0570","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ejmech.2017.02.039","article-title":"Design, synthesis and evaluation of novel ferulic acid-O-alkylamine derivatives as potential multifunctional agents for the treatment of Alzheimer's disease","volume":"130","author":"Sang","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107819_b0575","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.ejmech.2017.07.026","article-title":"Structure-activity relations of rosmarinic acid derivatives for the amyloid \u03b2 aggregation inhibition and antioxidant properties","volume":"138","author":"Taguchi","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107819_b0580","doi-asserted-by":"crossref","first-page":"4707","DOI":"10.1039\/D0FO00800A","article-title":"Lipophilic ferulic acid derivatives protect PC12 cells against oxidative damage via modulating \u03b2-amyloid aggregation and activating Nrf2 enzymes","volume":"11","author":"Wu","year":"2020","journal-title":"Food & Funct."},{"key":"10.1016\/j.bioorg.2024.107819_b0585","first-page":"1352","article-title":"Synthesis, anticholinesterase activity and molecular modeling study of novel carbamate-substituted thymol\/carvacrol derivatives, Bioorgan","volume":"25","author":"Kurt","year":"2017","journal-title":"Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107819_b0590","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ardp.201800209","article-title":"Novel sulfamate derivatives of menthol: Synthesis, characterization, and cholinesterases and carbonic anhydrase enzymes inhibition properties","volume":"351","author":"Daryadel","year":"2018","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.bioorg.2024.107819_b0595","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.bioorg.2018.12.013","article-title":"Ursolic and oleanolic acid derivatives with cholinesterase inhibiting potential","volume":"85","author":"Loesche","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2024.107819_b0600","first-page":"3370","article-title":"Amino derivatives of glycyrrhetinic acid as potential inhibitors of cholinesterases, Bioorgan","volume":"22","author":"Schwarz","year":"2014","journal-title":"Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107819_b0605","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.ijbiomac.2022.07.178","article-title":"Synthesis of 4-substituted benzyl-2-triazole-linked-tryptamine-paeonol derivatives and evaluation of their selective inhibitions against butyrylcholinesterase and monoamine oxidase-B","volume":"217","author":"Oh","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bioorg.2024.107819_b0610","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1016\/j.bmc.2017.02.048","article-title":"Design, synthesis, and evaluation of multitarget-directed ligands against Alzheimer\u2019s disease based on the fusion of donepezil and curcumin","volume":"25","author":"Yan","year":"2017","journal-title":"Bioorgan, Med, Chem"},{"key":"10.1016\/j.bioorg.2024.107819_b0615","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.3390\/molecules20011304","article-title":"Synthesis and Evaluation of Paeonol Derivatives as Potential Multifunctional Agents for the Treatment of Alzheimer\u2019s Disease","volume":"20","author":"Zhou","year":"2015","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2024.107819_b0620","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s11418-017-1097-2","article-title":"Nukoolkarn, Semisynthesis and biological evaluation of prenylated resveratrol derivatives as multi-targeted agents for Alzheimer\u2019s disease","volume":"71","author":"Puksasook","year":"2017","journal-title":"J. Nat. Med."},{"key":"10.1016\/j.bioorg.2024.107819_b0625","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.3233\/JAD-170071","article-title":"Assessment of Novel Curcumin Derivatives as Potent Inhibitors of Inflammation and Amyloid-\u03b2 Aggregation in Alzheimer\u2019s Disease","volume":"60","author":"Lakey-Beitia","year":"2017","journal-title":"J. Alzheimer's Dis."},{"key":"10.1016\/j.bioorg.2024.107819_b0630","doi-asserted-by":"crossref","first-page":"5843","DOI":"10.1021\/jm400567s","article-title":"Design, Synthesis, and Evaluation of Multitarget-Directed Resveratrol Derivatives for the Treatment of Alzheimer\u2019s Disease","volume":"56","author":"Lu","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107819_b0635","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2174\/15734099113099990007","article-title":"Experimental and Computational Studies on the Inhibition of Acetylcholinesterase by Curcumin and Some of its Derivatives","volume":"9","author":"Tello-Franco","year":"2013","journal-title":"Curr. Comput-Aid. Drug"},{"key":"10.1016\/j.bioorg.2024.107819_b0640","doi-asserted-by":"crossref","unstructured":"H.H. Zhang, Y.Y. Wang, D. Liu, J.F. Li, Y.Y. Feng, Y.M. Lu, G.F. Yin, Zhao Li, T. Shi, Z. Wang, Carbamate-based N-Substituted tryptamine derivatives as novel pleiotropic molecules for Alzheimer\u2019s disease, Bioorg. Chem. 125 (2022) 105844.","DOI":"10.1016\/j.bioorg.2022.105844"},{"key":"10.1016\/j.bioorg.2024.107819_b0645","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113649","article-title":"Nanomolar inhibition of human OGA by 2-acetamido-2-deoxy-Dglucono-1,5-lactone semicarbazone derivatives","volume":"223","author":"Kiss","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107819_b0650","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ejmech.2014.03.015","article-title":"Synthesis, cytotoxicity and molecular modelling studies of new phenylcinnamide derivatives as potent inhibitors of cholinesterases","volume":"78","author":"Saeed","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107819_b0655","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1021\/jm401824w","article-title":"Synthesis and Multitarget Biological Profiling of a Novel Family of Rhein Derivatives As Disease-Modifying Anti-Alzheimer Agents","volume":"57","author":"Viayna","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107819_b0660","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114210","article-title":"Development of 5-hydroxyl-1-azabenzanthrone derivatives as dual binding site and selective acetylcholinesterase inhibitors","volume":"234","author":"Sun","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107819_b0665","doi-asserted-by":"crossref","first-page":"8299","DOI":"10.1021\/jm200691d","article-title":"Synthesis of Monomeric Derivatives To Probe Memoquin\u2019s Bivalent Interactions","volume":"54","author":"Bolognesi","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107819_b0670","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1021\/acschemneuro.0c00624","article-title":"Multitarget Biological Profiling of New Naphthoquinone and Anthraquinone-Based Derivatives for the Treatment of Alzheimer\u2019s Disease","volume":"12","author":"Campora","year":"2021","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.bioorg.2024.107819_b0675","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ijbiomac.2012.04.012","article-title":"A new investigation for some steroidal derivatives as anti-Alzheimer agents","volume":"51","author":"Abdalla","year":"2012","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bioorg.2024.107819_b0680","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111913","article-title":"Design, synthesis and evaluation of diosgenin carbamate derivatives as multitarget anti-Alzheimer\u2019s disease agents","volume":"187","author":"Yang","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107819_b0685","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ardp.201900200","article-title":"Synthesis of \u03b2-amino acid derivatives and their inhibitory profiles against some metabolic enzymes","volume":"352","author":"Atmaca","year":"2019","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.bioorg.2024.107819_b0690","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1080\/14756366.2020.1847101","article-title":"Tuning the activity of iminosugars: novel N-alkylated deoxynojirimycin derivatives as strong BuChE inhibitors","volume":"36","author":"Ahuja-Casar\u00edn","year":"2020","journal-title":"J Enzym Inhib Med Ch"},{"key":"10.1016\/j.bioorg.2024.107819_b0695","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154125","article-title":"\u03b1-Mangostin derivative 4e as a PDE4 inhibitor promote proteasomal degradation of alpha-synuclein in Parkinson's disease models through PKA activation","volume":"101","author":"Chen","year":"2022","journal-title":"Phytomedicine"},{"key":"10.1016\/j.bioorg.2024.107819_b0700","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.ijbiomac.2019.06.167","article-title":"Potent and selective inhibition of human monoamine oxidase-B by 4-dimethylaminochalcone and selected chalcone derivatives","volume":"137","author":"Oh","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bioorg.2024.107819_b0705","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2174\/1871524918666180426125714","article-title":"Nitrocatechol Derivatives of Chalcone as Inhibitors of Monoamine Oxidase and Catechol-O-Methyltransferase","volume":"18","author":"Engelbrecht","year":"2018","journal-title":"Central Nervous System Agents in Medicinal Chemistry"},{"key":"10.1016\/j.bioorg.2024.107819_b0710","doi-asserted-by":"crossref","unstructured":"B. Mathew, G. U\u00e7ar, G.E. Mathew, S. Mathew, P. Kalatharakkal\u2005Purapurath, F. Moolayil, S. Mohan, S. Varghese\u2005Gupta, Monoamine Oxidase Inhibitory Activity: Methyl\u2010versus Chlorochalcone Derivatives, ChemMedChem 11 (2016) 2649-2655.","DOI":"10.1002\/cmdc.201600497"},{"key":"10.1016\/j.bioorg.2024.107819_b0715","doi-asserted-by":"crossref","unstructured":"H.D. Janse van Rensburg, L.J. Legoabe, G. Terre\u2019Blanche, Synthesis and Structure Activity Relationships of Chalcone based Benzocycloalkanone Derivatives as Adenosine A1 and\/or A2A Receptor Antagonists, Drug Research. 70 (2020) 243-256.","DOI":"10.1055\/a-1146-2996"},{"key":"10.1016\/j.bioorg.2024.107819_b0720","article-title":"Novel cudraisoflavone J derivatives as potent neuroprotective agents for the treatment of Parkinson's disease via the activation of Nrf2\/HO-1 signaling","volume":"242","author":"Lu","year":"2022","journal-title":"Eur. J. Me. Chem."},{"key":"10.1016\/j.bioorg.2024.107819_b0725","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/s41598-020-57417-9","article-title":"Design and Molecular dynamic Investigations of 7,8-Dihydroxyflavone Derivatives as Potential Neuroprotective Agents Against Alpha-synuclein","volume":"10","author":"Mohankumar","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2024.107819_b0730","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2020.127188","article-title":"Evaluation of nitrocatechol chalcone and pyrazoline derivatives as inhibitors of catechol-O-methyltransferase and monoamine oxidase","volume":"30","author":"Hitge","year":"2020","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2024.107819_b0735","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1002\/cmdc.201900717","article-title":"Novel, Dual Target-Directed Annelated Xanthine Derivatives Acting on Adenosine Receptors and Monoamine Oxidase B","volume":"15","author":"Kuder","year":"2020","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bioorg.2024.107819_b0740","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.3390\/molecules22061010","article-title":"Synthesis, Evaluation of Phenylxanthine Derivatives as Potential Dual A2AR Antagonists\/MAO-B Inhibitors for Parkinson\u2019s Disease","volume":"22","author":"Wang","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2024.107819_b0745","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2020.104807","article-title":"Highly efficient synthesis and monoamine oxidase B inhibitory profile of demethyleneberberine, columbamine and palmatine","volume":"139","author":"Tao","year":"2020","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.bioorg.2024.107819_b0750","doi-asserted-by":"crossref","first-page":"5053","DOI":"10.1016\/j.bmcl.2009.07.039","article-title":"Synthesis and evaluation of 6-methyl-3-phenylcoumarins as potent and selective MAO-B inhibitors","volume":"19","author":"Matos","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2024.107819_b0755","doi-asserted-by":"crossref","first-page":"4224","DOI":"10.1016\/j.bmcl.2011.05.074","article-title":"MAO inhibitory activity modulation: 3-Phenylcoumarins versus 3-benzoylcoumarins","volume":"21","author":"Matos","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2024.107819_b0760","doi-asserted-by":"crossref","first-page":"5479","DOI":"10.2147\/DDDT.S89961","article-title":"3-Coumaranone derivatives as inhibitors of monoamine oxidase","volume":"9","author":"Legoabe","year":"2015","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.bioorg.2024.107819_b0765","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ejmech.2013.02.009","article-title":"Novel (coumarin-3-yl)carbamates as selective MAO-B inhibitors: Synthesis, in vitro and in vivo assays, theoretical evaluation of ADME properties and docking study","volume":"63","author":"Matos","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107819_b0770","first-page":"3235","article-title":"Derivatives of caffeic acid, a natural antioxidant, as the basis for the discovery of novel nonpeptidic neurotrophic agents, Bioorgan","volume":"25","author":"Moosavi","year":"2017","journal-title":"Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107819_b0775","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.102037","article-title":"A mitochondria-targeted caffeic acid derivative reverts cellular and mitochondrial defects in human skin fibroblasts from male sporadic Parkinson's disease patients","volume":"45","author":"Deus","year":"2021","journal-title":"Redox. Biol."},{"key":"10.1016\/j.bioorg.2024.107819_b0780","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ejmech.2015.08.055","article-title":"Novel 2H-chromen-2-one derivatives of resveratrol: Design, synthesis, modeling and use as human monoamine oxidase inhibitors","volume":"103","author":"Ruan","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107819_b0785","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.jnutbio.2009.02.004","article-title":"Protective effects of pinostilbene, a resveratrol methylated derivative, against 6-hydroxydopamine-induced neurotoxicity in SH-SY5Y cells","volume":"21","author":"Chao","year":"2010","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.bioorg.2024.107819_b0790","doi-asserted-by":"crossref","first-page":"9862","DOI":"10.1038\/srep09862","article-title":"Curcumin Pyrazole and its derivative (N-(3-Nitrophenylpyrazole) Curcumin inhibit aggregation, disrupt fibrils and modulate toxicity of Wild type and Mutant \u03b1-Synuclein","volume":"5","author":"Ahsan","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2024.107819_b0795","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1016\/j.bmcl.2015.03.040","article-title":"The synthesis and evaluation of sesamol and benzodioxane derivatives as inhibitors of monoamine oxidase","volume":"25","author":"Engelbrecht","year":"2015","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2024.107819_b0800","doi-asserted-by":"crossref","first-page":"3594","DOI":"10.1021\/jm970328b","article-title":"Design, Synthesis, and Dopamine Receptor Modulating Activity of Diketopiperazine Peptidomimetics of L-Prolyl-L-leucylglycinamide","volume":"40","author":"Baures","year":"1997","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107819_b0805","first-page":"4963","article-title":"Synthesis of glutamic acid analogs as potent inhibitors of leukotriene A4 hydrolase, Bioorgan","volume":"16","author":"Kirkland","year":"2008","journal-title":"Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107819_b0810","doi-asserted-by":"crossref","first-page":"11633","DOI":"10.1523\/JNEUROSCI.0774-13.2013","article-title":"Tocopherol Derivative TFA-12 Promotes Myelin Repair in Experimental Models of Multiple Sclerosis","volume":"33","author":"Blanchard","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bioorg.2024.107819_b0815","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113655","article-title":"Silyl resveratrol derivatives as potential therapeutic agents for neurodegenerative and neurological diseases","volume":"223","author":"Belmonte-Reche","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107819_b0820","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.bbrc.2017.04.125","article-title":"A hydrocortisone derivative binds to GAPDH and reduces the toxicity of extracellular polyglutamine-containing aggregates","volume":"487","author":"Lazarev","year":"2017","journal-title":"Biochem. Bioph. Res. Co."},{"key":"10.1016\/j.bioorg.2024.107819_b0825","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuint.2015.10.004","article-title":"Protective effects of 3-alkyl luteolin derivatives are mediated by Nrf2 transcriptional activity and decreased oxidative stress in Huntington's disease mouse striatal cells","volume":"91","author":"Oliveira","year":"2015","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.bioorg.2024.107819_b0830","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1124\/jpet.114.216879","article-title":"Regulation of a Notch3-Hes1 Pathway and Protective Effect by a Tocopherol-Omega Alkanol Chain Derivative in Muscle Atrophy","volume":"352","author":"von Grabowiecki","year":"2015","journal-title":"J. Pharmacol. and Exp. Ther."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206824007247?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206824007247?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T02:23:08Z","timestamp":1738203788000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206824007247"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":166,"alternative-id":["S0045206824007247"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2024.107819","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent advances in the natural product analogues for the treatment of neurodegenerative diseases","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2024.107819","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107819"}}